Login to Your Account



Arena Raising $60M in Stock, Preps for Lorcaserin Panel

By Donna Young


Monday, August 9, 2010
Seeking to boost its balance sheet, Arena Pharmaceuticals Inc. Friday revealed a new direct public offering of 8.95 million shares at $6.70 per share, with expected proceeds of $60 million – $30 million of which the firm plans to use to prepay a portion of a loan. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription